Bosh sahifaZYDUSLIFE • NSE
add
Zydus Lifesciences Ltd
Yopilish kursi
902,40 ₹
Kunlik diapazon
898,30 ₹ - 908,00 ₹
Yillik diapazon
795,00 ₹ - 1 059,05 ₹
Bozor kapitalizatsiyasi
907,62 mlrd INR
Oʻrtacha hajm
685,19 ming
Narx/foyda
18,38
Dividend daromadliligi
1,22%
Asosiy maydon
NSE
Bozor yangiliklari
MarketWatch
1 kun oldin
The S&P 500 is undergoing a historic shift that could reshape the stock market
0,69%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 68,64 mlrd | 30,28% |
Joriy xarajat | 37,36 mlrd | 37,87% |
Sof foyda | 10,42 mlrd | 1,82% |
Sof foyda marjasi | 15,18 | -21,83% |
Har bir ulushga tushum | 10,96 | 7,68% |
EBITDA | 15,10 mlrd | 30,67% |
Amaldagi soliq stavkasi | 27,52% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 70,68 mlrd | 183,31% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 280,90 mlrd | — |
Tarqatilgan aksiyalar | 1,01 mlrd | — |
Narxi/balansdagi bahosi | 3,59 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 8,56% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 10,42 mlrd | 1,82% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
Tashkil etilgan
1952
Sayt
Xodimlar soni
27 917
